Wojewodzki Szpital Specjalistyczny W Bialej Podlaskiej — Clinical Trial Site

35 Registered trials

19 Currently recruiting

Organisation

Wojewodzki Szpital Specjalistyczny W Bialej Podlaskiej

Location

Biala Podlaska, Poland

Identifier

ORG-100047025

Address

Ul. Terebelska 57/65, 21-500, Poland

Departments

651: Oddzial Onkologii Klinicznej
Department of Clinical Oncology
Hematology
N/A
NA
Oddzial Chemioterapii Dziennej
Oddzial Onkologii Klinicznej
Oddział Hematologii
Oddział Onkologii Klinicznej
Oddział Onkologii Klnicznej
Osrodek Innowacyjnych Terapii
PL30005:Osrodek Innowacyjnych Terapii

Clinical trials at this site (35)

Search interface

DESTINY-Breast11 will compare trastuzumab deruxtecan (T-DXd) alone or in sequence with other medications, known as THP, with standard of car… Ended

2023-505210-18-00 Early stage HER2-positive breast cancer (T stage >= T3, 5 2021-12-17
A study comparing current available therapies with imetelstat for the treatment of intermediate-2 or high-risk MF who are not responding to … Ended

2023-509120-17-00 Myelofibrosis 5 2021-04-12
This is a randomized, double-blind, controlled trial to evaluate the efficacy and safety of cabozantinib in combination with nivolumab and i… Ended

2024-515616-47-00 Metastatic Renal Cell Carcinoma 5 2019-10-03
A Study of Nivolumab Combined with Ipilimumab Versus Nivolumab Alone in Participants with Advanced Kidney Cancer. Ended

2023-508264-29-00 Advanced Renal Cell Carcinoma with Intermediate- or Poo 5 2019-06-11
A Multicenter, Open-Label Clinical Trial of RVU120 in Patients with Relapsed or Refractory High-Risk Myelodysplastic Syndrome or Acute Myelo… Ended

2023-505910-10-00 Relapsed or Refractory High-Risk Myelodysplastic Syndro 4 2024-01-23
A PHASE 2, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY TO INVESTIGATE THE EFFICACY, SAFETY AND TOLERABILITY OF PONSEGROMAB IN PATIENT… Ended

2023-510446-24-00 Cancer cachexia 4 2023-05-30
Study to Compare Tivozanib in Combination with Nivolumab to Tivozanib Monotherapy in Subjects with Renal Cell Carcinoma Ended

2024-514570-43-00 Renal cell carcinoma 5 2022-01-24
A Study of Subcutaneous Nivolumab in Previously Treated Advanced or Metastatic Clear Cell Renal Cell Carcinoma Ended

2023-503280-42-00 Metastatic Clear Cell Renal Cell Carcinoma 5 2021-06-01
Study of Romiplostim for Chemotherapy-induced Thrombocytopenia in Adult Subjects with Gastrointestinal, Pancreatic, or Colorectal Cancer Ended

2023-507148-35-00 Chemotherapy-induced Thrombocytopenia in Adult Subjects 5 2019-10-03
A Phase 3, Randomized, Open-Label Study of Nivolumab Combined with Cabozantinib versus Sunitinib in Participants with Previously Untreated, … Ended

2023-509711-83-00 Advanced or Metastatic Renal Cell Carcinoma 5 2017-10-27
Efficacy and safety of the proposed biosimilar PERT-IJS versus EU-Perjeta® along with trastuzumab and chemotherapy (carboplatin and docetaxe… Ended

2023-506163-34-00 Hormone Receptor Negative (HR-ve) Human Epidermal Growt 5